CANbridge
CANbridge is a biopharmaceutical company that develops and commercializes drugs for the treatment of cancer and orphan diseases.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed CANbridge Information
Geographic Data
Address: No. 17 RongChuang Road
City: Chaoyang District
State: beijing municipality
Zip: 100102
Country: CN
Financial Info
Stage:
series e
Raised Last:
$43M
Raised Total:$224M
Social
Metrics
1,757,599Website Global Rank
13,012Website Monthly Traffic
Twitter Followers
Description
CANbridge is a biopharmaceutical company that develops and commercializes drugs for the treatment of cancer and orphan diseases.
Contact Phone:
Contact Email:
CANbridge went public on 12/10/2021 on the Hong Kong Stock Exchange
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
12/10/2021
Ticker Symbol:
1228
IPO Price:
$1.6413086615576662/share
Amount Raised:
$77M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
